To Die or not to die: An overview of apoptosis and its role in disease

JAMA

Volumn 279, Issue 4, 1998, Pages 300-307

  Hetts, Steven W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADENOSINE TRIPHOSPHATE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; AMYLOID BETA PROTEIN; ANTINUCLEAR ANTIBODY; CELL SURFACE PROTEIN; CYTOCHROME C; CYTOKINE; DNA; DOPAMINE; ENDONUCLEASE; FAS LIGAND; GROWTH FACTOR; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLSERINE; PRESENILIN 2; PROTEIN BAX; PROTEIN P53; PROTEINASE; REACTIVE OXYGEN METABOLITE; RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SELEGILINE; SUPEROXIDE DISMUTASE; T LYMPHOCYTE RECEPTOR; THROMBOSPONDIN; UNINDEXED DRUG; VIRUS PROTEIN;

ALZHEIMER DISEASE; APOPTOSIS; AUTOIMMUNE DISEASE; CELL CYCLE; CELL DEATH; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; DEGENERATIVE DISEASE; GENE; GENE MUTATION; GENE THERAPY; GRAFT REJECTION; HEART DISEASE; HUMAN; IMMUNE SYSTEM; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; SENESCENCE;

EID: 0032573853     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.4.300     Document Type: Review

References (78)

1. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26: 239-257.
2. Clarke PGH. Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol. 1990;181:195-213.
3. Cotran RS, Kumar V, Robbins SL. Cellular injury and cellular death. In: Cotran RS, Kumar V, Robbins SL, eds. Pathologic Basis of Disease. 5th ed. Philadelphia, Pa: WB Saunders Co; 1994:1-34.
4. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol. 1995; 146:3-15.
5. Hockenbery DM. bcl-2, a novel regulator of cell death. Bioessays. 1995;17:631-638.
6. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science. 1995;267:1456-1462.
7. Ellis RE, Yuan H, Horvitz HR. Mechanisms and functions of cell death. Ann Rev Cell Dev Biol. 1991; 7:663-698.
8. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-1449.
9. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell. 1993 74:777-779.
10. Vaux DL, Haecker G, Strasser A. An evolutionary perspective on apoptosis. Cell. 1994;76:777-779.
11. Yuan J-Y, Horvitz RH. Genetic mosaic analysis of ced-3 and ced-4, two genes that control programmed cell death in the nematode C elegans. Dev Biol. 1990;138:33-41.
12. Hengartner MO, Ellis RE, Horvitz RH. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature. 1992;356:494-499.
13. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science. 1997; 275:1122-1126.
14. Wu D, Wallen HD, Nuñez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science. 1997;275:1126-1129.
15. Spector MS, Desnoyers S, Hoeppner DJ, Hengartner MO. Interactions between the C elegans cell-death regulators CED-9 and CED-4. Nature. 1997;385:653-656.
16. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-kB activation. Cell. 1995;81:495-504.
17. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 1995;81:505-512.
18. Stanger BZ, Leder P, Lee T-H, et al. RIP: A novel protein containing a death domain that interacts with FAS/APO-1 (CD95) in yeast and causes cell death. Cell 1995;81:513-523.
19. Hsu H, Shu H-B, Pan M-G, Goeddel DV. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell. 1996;84:299-308.
20. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a Novel MORT1/ FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell. 1996;85:803-815.
21. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-Iike protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 1996;85:817-827.
22. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
23. Nagata S. Apoptosis by death factor. Cell. 1997; 88:355-365.
24. Van Parijs L, Ibraghimov A, Abbas AK. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 1996;4:321-328.
25. Abbas AK. Die and let live: eliminating dangerous lymphocytes. Cell. 1996;84:655-657.
26. Raff MC. Social controls on cell survival and cell death. Nature. 1992;356:397-400.
27. Vaux DL, Strasser A. The molecular biology of apoptosis. Proc Nat Acad Sci USA. 1996;93:2239-2244.
28. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171.
29. Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirements for DATP and cytochrome c. Cell. 1996;86: 147-157.
30. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 1997;90:405-413.
31. Yang J, Liu X, Bhalla K, et al. Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997;275:1129-1132.
32. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for bcl-2 regulation of apoptosis. Science. 1997;275:1132-1136.
33. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoeitic cell survival and cooperates with c-myc to immortalize pre-β cells. Nature. 1988; 335:440-442.
34. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Ann Rev Immunol. 1995;13: 513-543.
35. Vaux DL. CED-4 - the third horseman of apoptosis. Cell. 1997;90:389-390.
36. Reed JC. Double identity for proteins of the bcl-2 family. Nature. 1997;387:773-776.
37. Gajewski TF, Thompson CB. Apoptosis meets signal transduction: elimination of a BAD influence. Cell. 1996;87:589-592.
38. Antonsson B, Conti F, Ciavatta A, et al. Inhibition of Bax channel-forming activity by bcl-2. Science. 1997;277:370-372.
39. Golstein P. Controlling cell death. Science. 1997; 275:1081-1082.
40. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today. 1997;18: 44-51.
41. Cheng E, Kirsch DG, Clem R, et al. Conversion of Bcl-2 to a BAX-like death effector by caspases. Science. 1997;278:1966-1968.
42. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med. 1994; 179:1317-1330.
43. Streilein JW. Unraveling immune privilege. Science. 1995;270:1158-1159.
44. Griffith TS, Brunner T, Fletcher SM, et al. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science. 1995;270:1189-1192.
45. Bellgrau D, Gold D, Selawry H, et al. A role for CD95 ligand in preventing graft rejection. Nature. 1995;377:630-632.
46. Benoist C, Mathis D. Cell death mediators in autoimmune diabetes - no shortage of suspects. Cell. 1997;89:1-3.
47. Lau HT, Yu M, Fontana A, Stoeckert CJ Jr. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science. 1996;273:109-112.
48. Chernovsky AV, Wang Y, Wong, FS, et al. The role of Fas in autoimmune diabetes. Cell. 1997;89: 17-24.
49. Giordano C, Stassi G, De Maria R, et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science. 1997; 275:960-963.
50. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J Exp Med. 1996;183:1031-1036.
51. Roquet N, Pages J-C, Molina T, Briand P, Joulin V. ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis. Curr Biol. 1996;6:1192-1195.
52. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science. 1995;268:1347-1349.
53. Fisher GH, Rosenberg FJ, Straus SE, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell. 1995;81:935-946.
54. Drappa J, Vaishnaw AK, Sullivan KE, Chu JL, Elkon KB. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med. 1996;335:1643-1649.
55. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell. 1994;78:539-542.
56. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell. 1997;88:323-331.
57. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature. 1997;389:300-305.
58. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature. 1997;385:637-640.
59. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 1997;275:967-969.
60. Hahne M, Rimoldi D, Schroter M, et al. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science. 1996;274:1363-1366.
61. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells - a mechanism of immune evasion? Nat Med. 1996;2:1361-1366.
62. Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219-228.
63. Lipton SA. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species. Brain Pathol. 1996;6:507-517.
64. Bredesen DE. Neural apoptosis. Ann Neurol. 1995;38:839-851.
65. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, Przedborski S. bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 1997;277:559-562.
66. Vito P, Lacana E, D'Adamio L. Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science. 1996;271:521-525.
67. Wolozin B, Iwasaki K, Vito P, et al. Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science. 1996;274:1710-1713.
68. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A. Amyloid beta peptide of Alzheimer's disease downregulates bcl-2 and upregulates box expression in human neurons. J Neurosci. 1996;16:7533-7539.
69. Jenner P, Olanow CW. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 1996;47:S161-S170.
70. Tompkins MM, Basgall EJ, Zamrini E, Hill WD. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am J Pathol. 1997;150:119-131.
71. Tatton WG, Chalmers-Redman RM. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology. 1996;47: S171-S183.
72. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 1996;335:1182-1189.
73. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119:493-501.
74. Olivetti G, Abbi R, Quaini F, et al. Apoptosis in the failing human heart. N Engl J Med. 1997;336: 1131-1141.
75. Colucci WS. Apoptosis in the heart. N Engl J Med. 1996;335:1224-1226.
76. Mallat A, Tedgui A, Fontaliran F, et al. Evidence of apoptosis in arrhythmogenic right ventricular dysplasia. N Engl J Med. 1996;335:1190-1196.
77. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376:37-43.
78. Bischoff JR, Kirn DH, Williams A, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996;274: 373-376.